marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q1
added 12-23-2023
Entasis Therapeutics Holdings Financial Ratios 2011-2024 | ETTX
Annual Financial Ratios Entasis Therapeutics Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -1.3 | -1.6 | -0.6 | - | - | - | - | - | - | - |
P/S |
- | - | 9.9 | 4.0 | - | - | - | - | - | - | - |
EPS |
-1.1 | -2.1 | -3.3 | -12.3 | -13795.8 | - | - | - | - | - | - |
EV (Enterprise Value) |
51.1 M | 20 M | 62.2 M | -23.1 M | 59.5 M | 53.4 M | - | - | - | - | - |
EBITDA per Share |
-1.2 | -2.25 | -3.56 | -11.1 | - | - | - | - | - | - | - |
EV/EBITDA |
-0.4 | -0.8 | -1.1 | 1.0 | - | - | - | - | - | - | - |
PEG |
- | 0.12 | -0.02 | 0.01 | - | - | - | - | - | - | - |
P/B |
2.4 | 1.2 | 1.6 | 0.2 | - | - | - | - | - | - | - |
P/CF |
-1.7 | -1.4 | -1.6 | -0.6 | - | - | - | - | - | - | - |
ROE % |
-151.03 | -96.57 | -104.02 | -39.76 | - | - | - | - | - | - | - |
ROA % |
-115.20 | -82.03 | -85.92 | -36.91 | - | - | - | - | - | - | - |
ROCE % |
-167.62 | -102.34 | -107.95 | -46.00 | - | - | - | - | - | - | - |
Current Ratio |
4.2 | 6.6 | 5.7 | 14.0 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Entasis Therapeutics Holdings
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | -0.32 | - | -0.26 | -0.29 | -0.29 | - | -0.37 | -0.78 | -1.15 | - | -0.27 | -1.02 | -0.99 | - | -20.33 | -453.6 | -844.01 | - | -5106.75 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | -0.33 | - | -0.29 | -0.32 | -0.34 | - | -0.35 | -0.78 | -1.16 | - | -0.31 | -1.07 | -1.08 | - | -11.6 | -549 | -927 | - | -5.13 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-183.36 | -213.41 | -151.78 | -174.45 | -76.90 | -94.79 | -82.63 | -87.14 | -100.17 | -106.52 | -94.98 | -90.94 | -60.18 | -70.40 | -74.28 | -58.06 | -30.01 | -15.09 | 10.05 | 16.97 | 14.92 | 14.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-69.23 | -93.64 | -83.43 | -102.36 | -63.59 | -79.50 | -71.01 | -75.81 | -83.68 | -90.51 | -81.43 | -83.92 | -58.41 | -67.90 | -70.56 | -50.76 | -27.86 | -42.02 | -46.69 | -40.26 | -14.16 | -14.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-191.36 | -224.35 | -161.65 | -186.71 | -86.69 | -106.94 | -94.20 | -96.49 | -103.19 | -110.71 | -97.98 | -95.01 | -65.55 | -77.81 | -82.56 | -66.66 | -34.94 | -19.68 | 7.84 | 16.32 | 15.26 | 15.26 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 1.6 | 4.2 | 5.3 | 6.0 | 6.2 | 6.6 | 9.1 | 7.9 | 5.0 | 5.8 | 5.8 | 5.8 | 5.8 | 14.0 | 14.0 | 14.0 | 14.0 | 6.0 | 6.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency